On July 9, 2026, ARK Invest made significant portfolio adjustments, highlighted by a purchase of 34,080 shares of Meta Platforms, valued at $20.55 million. This strategic acquisition comes right before the company's Q2 earnings report, anticipated on July 29, when Meta is expected to report earnings per share of $7.17 alongside revenues of $60.19 billion.
Investors have shown confidence in Meta, which holds a Strong Buy consensus rating from Wall Street, with an average price target of $817.15. This represents a potential upside of approximately 29.4% from current levels, despite the stock's year-to-date decline of 4.2%. The move towards Meta follows a series of AI-related announcements from the company, including the launch of its first paid AI model and plans for mass production of the Iris AI chip, slated for September.
In contrast, ARK reduced its stake in Advanced Micro Devices (AMD), selling 10,774 shares for $5.57 million. This sale is part of a broader trend in which ARK has been trimming its positions in several holdings, having also sold shares of Robinhood Markets and Roku. Other noted transactions included unloading Twist Bioscience shares.
Further diversifying its investments, ARK acquired 217,896 shares of Circle Internet Group across several ETFs, totaling $13.96 million. Along with this, ARK increased its positions in Ionis Pharmaceuticals and Prime Medicine, with additional smaller purchases in biotech segments.
The response to ARK's investment moves was immediate, with Meta stock rising 6.58% on July 10, following the disclosure of ARK's purchase.
This material is for informational purposes only and does not constitute financial advice.
